NAV$136.96M
Invested$122.65M
Distributions$23.66M
TVPI1.31x
Active positions37
Private-markets monitor

Willowbrook Pet Care

Everything that has happened with this deal, newest first — the updates, calls and financials they've sent, and the money that's come back.

Events
16
on the record
Documents
15
13 read & summarised
Distributions
0
cash returned
Invested
$2.75M
2024-09-01
Current value
$3.05M

History

16 shown
2026
09-30 Willowbrook slightly ahead of plan in Q3 2026 Update 5 figures
Revenue of $4.39M was 5% ahead of the $4.20M budget, up 25% on a year earlier. EBITDA of $662K (15% margin) beat plan by 13%. The full-year plan is unchanged; the beat is mostly volume.
06-30 Willowbrook: Q2 2026 in line with budget Update 5 figures
Revenue of $4.12M was in line with the $4.01M budget, up 19% on a year earlier. EBITDA of $526K (13% margin) was 6% short of plan. No changes to the team or the capital structure.
03-31 Willowbrook on plan in Q1 2026 Update 5 figures
Revenue of $3.84M was in line with the $3.84M budget, up 15% on a year earlier. EBITDA of $517K (13% margin) was on plan. Nothing in the package changes the full-year view.
01-11 Willowbrook 2026 budget approved: revenue $16.4M Financials
The board-approved 2026 budget plans revenue of $16.4M, 17% above 2025's actual revenue, and EBITDA of $2.30M, a 14% margin.
2025
12-31 Willowbrook adds a veterinary group Update 5 figures
A four-clinic veterinary group joined in the quarter, funded from the delayed-draw facility. Revenue of $3.69M was in line with the $3.68M budget, up 21% on a year earlier. EBITDA of $530K (14% margin) was on plan.
12-31 Willowbrook FY2025 audit: clean opinion Financials
The auditors issued an unqualified opinion on FY2025. Audited revenue of $14.0M and EBITDA of $2.01M agree with the monthly packages to within 0.3%; no adjustments were booked.
12-31 Tax document Tax document
09-30 Willowbrook: Q3 2025 in line with budget Update 5 figures
Revenue of $3.52M was in line with the $3.52M budget, up 19% on a year earlier. EBITDA of $490K (14% margin) was on plan. No changes to the team or the capital structure.
06-30 Willowbrook on plan in Q2 2025 Update 5 figures
Revenue of $3.46M was in line with the $3.37M budget, up 3% on the prior quarter. EBITDA of $512K (15% margin) beat plan by 9%. Nothing in the package changes the full-year view.
03-31 Willowbrook opens three clinics Update 5 figures
Three clinics opened in suburban markets; two are ahead of their first-year visit targets. Revenue of $3.35M was 4% ahead of the $3.22M budget, up 10% on the prior quarter. EBITDA of $476K (14% margin) beat plan by 5%.
01-23 Willowbrook 2025 budget approved: revenue $13.8M Financials
The board-approved 2025 budget plans revenue of $13.8M, 20% above 2024's actual revenue, and EBITDA of $1.93M, a 14% margin.
2024
12-31 Willowbrook on plan in Q4 2024 Update 5 figures
Revenue of $3.05M was in line with the $3.08M budget, up 3% on the prior quarter. EBITDA of $454K (15% margin) beat plan by 5%. Nothing in the package changes the full-year view.
09-30 Willowbrook: Q3 2024 in line with budget Update 5 figures
Revenue of $2.95M was in line with the $2.95M budget. EBITDA of $444K (15% margin) beat plan by 7%. No changes to the team or the capital structure.
09-15 Willowbrook 2024 budget approved: revenue $11.6M Financials
The board-approved 2024 budget plans revenue of $11.6M, 22% above 2023's actual revenue, and EBITDA of $1.62M, a 14% margin.
09-01 Invested $2.75M
Undated
— Legal document Legal document

Every entry is a real record — click a filename to open the original in SharePoint. Documents in grey are on file but haven't been read yet, so they show as an event without a summary; run the extractor to fill them in. “Significant” marks an update that changes the investment case, as opposed to routine reporting.

Static demo · synthetic data · read-only  ↩